- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
GLP-1 Drugs Emerge as Popular Weight Loss Option
Brown University professor Dr. Emily Oster discusses the impact of GLP-1 medications on weight loss.
Mar. 30, 2026 at 10:20pm
Got story updates? Submit your updates here. ›
Just a few years ago, the term 'GLP-1' was relatively unknown, but these drugs have now become a popular option for weight loss under various brand names. Dr. Emily Oster, a Brown University professor and CEO of Parent Data, recently joined a local news program to share insights on the effectiveness, side effects, and potential for treating other diseases with GLP-1 medications.
Why it matters
As obesity rates continue to rise, new weight loss treatments like GLP-1 drugs have gained significant attention and interest from both patients and the medical community. Understanding the impact and implications of these medications is crucial for individuals seeking effective weight management solutions.
The details
GLP-1 drugs, or glucagon-like peptide-1 receptor agonists, work by mimicking a hormone that regulates blood sugar levels and appetite. This can lead to reduced calorie intake and increased fat burning, resulting in weight loss for many patients. Dr. Oster discussed the potential side effects of GLP-1 medications, such as nausea and gastrointestinal issues, as well as the possibility of using these drugs to treat other conditions beyond weight loss.
- GLP-1 drugs have become more widely known and used in the past few years.
The players
Dr. Emily Oster
A Brown University professor and CEO of Parent Data, who provided insights on the impact of GLP-1 drugs for weight loss.
WPRI
A local news station in Providence, Rhode Island, that hosted the interview with Dr. Oster.
What they’re saying
“Just a few years ago, 'GLP-1' wasn't a commonly known term. Now, it's become a popular drug being marketed for weight loss under different brand names.”
— Dr. Emily Oster, Brown University Professor and CEO of Parent Data
The takeaway
As the medical community continues to explore the potential of GLP-1 drugs for weight loss and other health conditions, understanding the benefits, risks, and implications of these medications will be crucial for individuals seeking effective and safe treatment options.
